University of California, BerkeleyCo-Director, Molecular Therapeutics Initiative; Professor of Chemical Biology and Molecular Therapeutics
2024 — Present
Dan Nomura is an investment advisory partner at a16z Bio + Health and a professor of chemical biology and molecular therapeutics at UC Berkeley. He co-directs Berkeley’s Molecular Therapeutics Initiative, holds an adjunct professorship at UCSF, and founded Frontier Medicines and Vicinitas Therapeutics to translate chemoproteomics into new medicines. He previously completed postdoctoral research at Scripps Research.
Dan Nomura is an investment advisory partner at a16z Bio + Health and a professor of chemical biology and molecular therapeutics at UC Berkeley. He co-directs Berkeley’s Molecular Therapeutics Initiative, holds an adjunct professorship at UCSF, and founded Frontier Medicines and Vicinitas Therapeutics to translate chemoproteomics into new medicines. He previously completed postdoctoral research at Scripps Research.
Career
Andreessen Horowitz (a16z)Advisory Partner, Bio + Health
2023 — Present
Vicinitas TherapeuticsFounder and Chair of Board of Directors
2022 — Present
University of California, San FranciscoAdjunct Professor, Pharmaceutical Chemistry
2019 — Present
Frontier MedicinesCo-Founder and Chair of Scientific Advisory Board
2018 — Present
Novartis-Berkeley Translational Chemical Biology InstituteDirector
2017 — Present
Scripps ResearchPostdoctoral Fellow, Chemical Physiology
2008 — 2011